Login / Signup

Usefulness of Plasma Amyloid as a Prescreener for the Earliest Alzheimer Pathological Changes Depends on the Study Population.

Samantha PrinsAhnjili ZhuparrisGeert Jan Groeneveld
Published in: Annals of neurology (2019)
Keyphrases
  • mild cognitive impairment